China National Accord Medicines Corporation Ltd. announced unaudited earnings results for the six months ended June 30, 2016. For the period, the company reported operating income of RMB 14,089,052,871.88 compared to RMB 12,813,803,166.77 a year ago. Net profit attributable to shareholders of the company was RMB 542,122,083.86 compared to RMB 387,319,252.33 a year ago. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was RMB 404,509,408.41 compared to RMB 373,659,153.79 a year ago. Net cash outflow from operating activities of RMB 100,461,465.99 compared to net cash flows from operating activities of RMB 182,179,606.70 a year ago. Diluted earnings per share was RMB 1.495 compared to RMB 1.068 a year ago. Weighted average ROE was 9.53% compared to 7.85% a year ago.